Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ENDRES S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tschoep, K; Hartmann, G; Jox, R; Thompson, S; Eigler, A; Krug, A; Erhardt, S; Adams, G; Endres, S; Delius, M
      Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotides

      JOURNAL OF MOLECULAR MEDICINE-JMM
    2. Siegmund, B; Welsch, J; Loher, F; Meinhardt, G; Emmerich, B; Endres, S; Eigler, A
      Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptoticmembers of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis

      LEUKEMIA
    3. Jahrsdorfer, B; Hartmann, G; Racila, E; Jackson, W; Muhlenhoff, L; Meinhardt, G; Endres, S; Link, BK; Krieg, AM; Weiner, GJ
      CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens

      JOURNAL OF LEUKOCYTE BIOLOGY
    4. Zou, W; Hakim, I; Tschoep, K; Endres, S; Bar-Shavit, Z
      Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclastdifferentiation by an autocrine mechanism

      JOURNAL OF CELLULAR BIOCHEMISTRY
    5. Siegmund, B; Fantuzzi, G; Rieder, F; Gamboni-Robertson, F; Lehr, HA; Hartmann, G; Dinarello, CA; Endres, S; Eigler, A
      Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    6. Siegmund, B; Rieder, F; Albrich, S; Wolf, K; Bidlingmaier, C; Firestein, GS; Boyle, D; Lehr, HA; Loher, F; Hartmann, G; Endres, S; Eigler, A
      Adenosine kinase inhibitor GP515 improves experimental colitis in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. Burchardi, C; Angstwurm, M; Endres, S
      Spectrum of diagnoses during an emergency admission

      INTERNIST
    8. Werdan, K; Endres, S
      Cytokines and anti-cytokine therapies

      INTERNIST
    9. Eigler, A; Loher, F; Endres, S
      Suppression of tumor necrosis factor synthesis

      INTERNIST
    10. Krug, A; Rothenfusser, S; Hornung, V; Jahrsdorfer, B; Blackwell, S; Ballas, ZK; Endres, S; Krieg, AM; Hartmann, G
      Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    11. Krug, A; Towarowski, A; Britsch, S; Rothenfusser, S; Hornung, V; Bals, R; Giese, T; Engelmann, H; Endres, S; Krieg, AM; Hartmann, G
      Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

      EUROPEAN JOURNAL OF IMMUNOLOGY
    12. Hacker, UT; Erhardt, S; Tschop, K; Jelinek, T; Endres, S
      Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1 beta after live yellow fever vaccination

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    13. Schnurr, M; Galambos, P; Scholz, C; Then, F; Dauer, M; Endres, S; Eigler, A
      Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines

      CANCER RESEARCH
    14. Heiss, D; Konig, A; Endres, S; Pfluger, T; Pfeifer, KJ; Hahn, K
      Combined PACS and intranet information system in a university hospital.

      ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    15. Hartmann, G; Tschop, M; Fischer, R; Bidlingmaier, C; Riepl, R; Tschop, K; Hautmann, H; Endres, S; Toepfer, M
      High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein

      CYTOKINE
    16. Eigler, A; Matschke, V; Hartmann, G; Erhardt, S; Boyle, D; Firestein, GS; Endres, S
      Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor

      JOURNAL OF LEUKOCYTE BIOLOGY
    17. Tuma, E; Eigler, A; Toepfer, M; Endres, S; Schiffl, H
      IL-1 receptor antagonist production by isolated mononuclear cells is a better indicator of bioincompatibility of hemodialysis membranes than that by stimulated whole blood

      NEPHRON
    18. Hartmann, G; Bidlingmaier, C; Siegmund, B; Albrich, S; Schulze, J; Tschoep, K; Eigler, A; Lehr, HA; Endres, S
      Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Schnurr, M; Then, F; Galambos, P; Scholz, C; Siegmund, B; Endres, S; Eigler, A
      Extracellular ATP and TNF-alpha synergize in the activation and maturationof human dendritic cells

      JOURNAL OF IMMUNOLOGY
    20. Brunner, C; Seiderer, J; Schlamp, A; Bidlingmaier, M; Eigler, A; Haimerl, W; Lehr, HA; Krieg, AM; Hartmann, G; Endres, S
      Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo

      JOURNAL OF IMMUNOLOGY
    21. Endres, S; Hacker, A; Noack, E; Kojda, G; Lehmann, J
      NO-Donors, part 3: nitrooxyacylated thiosalicylates and salicylates - synthesis and biological activities

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    22. Schulze, J; Toepfer, M; Schroff, KC; Aschhoff, S; Remien, J; Muller-Felber, W; Endres, S
      Clindamycin and nicotinic neuromuscular transmission

      LANCET
    23. WOLF K; BIDLINGMAIER C; SIEGMUND B; HARTMANN G; EIGLER A; LEHR HA; ENDRES S
      ROLIPRAM, A SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITOR, MITIGATES EXPERIMENTAL COLITIS IN MICE

      European cytokine network
    24. TSCHOP K; HARTMANN G; THOMPSON S; ERHARDT S; DELIUS M; ENDRES S
      SUPPRESSION OF TUMOR-NECROSIS-FACTOR-A SYNTHESIS IN HUMAN MONONUCLEAR-CELLS VIA SHOCK WAVE-DELIVERED ANTISENSE OLIGONUCLEOTIDES

      European cytokine network
    25. MOELLER J; EIGLER A; HACKL A; ZARSKYJ D; ENDRES S
      DETECTION OF AN NO-INDUCING ACTIVITY IN CONDITIONED MEDIUM OF HUMAN MONONUCLEAR-CELLS WHICH ACTS ON MURINE MACROPHAGE-LIKE CELLS IN SYNERGYWITH INTERFERON-G

      European cytokine network
    26. ERHARDT SK; HACKER UT; BIDLINGMAIER M; TSCHOP K; JELLINEK T; NORTHDURFT HD; ENDRES S
      ENHANCED TNF-A PLASMA-CONCENTRATIONS AFTER YELLOW-FEVER VACCINATION -DIFFERENT VACCINES INDUCE DIFFERENT RESPONSES

      European cytokine network
    27. TUMA E; EIGLER A; TOEPFER M; OLMA M; BRUNNER C; ENDRES S; SCHIFFL H
      INTERLEUKIN-1 RECEPTOR ANTAGONIST PRODUCTION AND IL-18 MESSENGER-RNA AS MARKERS FOR BIOCOMPATIBILITY OF EXTRACORPOREAL MEMBRANES

      European cytokine network
    28. SINHA B; EIGLER A; BAUMANN KH; GRETEN TF; MOELLER J; ENDRES S
      NITRIC-OXIDE DOWN-REGULATES TUMOR-NECROSIS-FACTOR MESSENGER-RNA IN RAW-264.7 CELLS

      Research in immunology
    29. HARTMANN G; BIDLINGMAIER C; TSCHOP K; EIGLER A; LEHR HA; ENDRES S
      THE SPECIFIC TYPE-IV PHOSPHODIESTERASE INHIBITOR ROLIPRAM MITIGATES EXPERIMENTAL COLITIS IN MICE

      The FASEB journal
    30. EIGLER A; SIEGMUND B; EMMERICH U; BAUMANN KH; HARTMANN G; ENDRES S
      ANTIINFLAMMATORY ACTIVITIES OF CAMP-ELEVATING AGENTS - ENHANCEMENT OFIL-10 SYNTHESIS AND CONCURRENT SUPPRESSION OF TNF PRODUCTION

      Journal of leukocyte biology
    31. HARTMANN G; BIDLINGMAIER M; JAHRSDORFER B; KRUG A; HACKER U; EIGLER A; ENDRES S
      OLIGONUCLEOTIDE UPTAKE IN LEUKOCYTES IS DEPENDENT ON EXTRACELLULAR CALCIUM - A HINT FOR THE INVOLVEMENT OF ADHESION MOLECULES

      Nucleosides & nucleotides
    32. SIEGMUND B; EIGLER A; HARTMANN G; HACKER U; ENDRES S
      ADRENALINE ENHANCES LPS-INDUCED IL-10 SYNTHESIS - EVIDENCE FOR PROTEIN-KINASE A-MEDIATED PATHWAY

      International journal of immunopharmacology
    33. EIGLER A; WALLERFONTAINE K; MOELLER J; HARTMANN G; HACKER UT; ENDRES S
      THE HAIRY-CELL LEUKEMIA-CELL LINE ESKOL SPONTANEOUSLY SYNTHESIZES TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE

      Leukemia research
    34. TSCHOP K; HARTMANN G; KRUG A; ADAMS G; DELIUS M; ENDRES S
      DELIVERY OF ANTISENSE OLIGONUCLEOTIDES INTO THE CELL - A NEW TECHNIQUE APPLICABLE TO LEUKOCYTES AND LEUKEMIC-CELLS

      Naunyn-Schmiedeberg's archives of pharmacology
    35. TSCHOP K; HARTMANN G; KRUG A; ADAMS G; DELIUS M; ENDRES S
      DELIVERY OF ANTISENSE OLIGONUCLEOTIDES INTO THE CELL - A NEW TECHNIQUE APPLICABLE TO LEUKOCYTES AND LEUKEMIC-CELLS

      Naunyn-Schmiedeberg's archives of pharmacology
    36. HARTMANN G; KRUG A; BIDLINGMAIER M; HACKER U; EIGLER A; ALBRECHT R; STRASBURGER CJ; ENDRES S
      SPONTANEOUS AND CATIONIC LIPID-MEDIATED UPTAKE OF ANTISENSE OLIGONUCLEOTIDES IN HUMAN MONOCYTES AND LYMPHOCYTES

      The Journal of pharmacology and experimental therapeutics
    37. HACKER UT; JELINEK T; ERHARDT S; EIGLER A; HARTMANN G; NOTHDURFT HD; ENDRES S
      IN-VIVO SYNTHESIS OF TUMOR-NECROSIS-FACTOR-ALPHA IN HEALTHY HUMANS AFTER LIVE YELLOW-FEVER VACCINATION

      The Journal of infectious diseases
    38. TOEPFER M; RIEPL RL; MULLERFELBER W; ENDRES S; FOLWACZNY C
      NONINVASIVE C-13-OCTANOIC ACID BREATH TEST SHOWS DELAYED GASTRIC-EMPTYING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS

      Gastroenterology
    39. BIDLINGMAIER C; HARTMANN G; TSCHOP K; EIGLER A; LEHR HA; ENDRES S
      THE SPECIFIC TYPE-IV PHOSPHODIESTERASE INHIBITOR ROLIPRAM MITIGATES EXPERIMENTAL, COLITIS IN MICE

      Gastroenterology
    40. HACKER UT; BIDLINGMAIER C; GOMOLKA M; KELLER E; EIGLER A; HARTMANN G; FOLWACZNY C; FRICKE H; ALBERT E; LOESCHKE K; ENDRES S
      INFLAMMATORY BOWEL-DISEASE - NO ASSOCIATION BETWEEN ALLELE COMBINATIONS OF THE INTERLEUKIN (IL) 1-BETA AND IL-1 RECEPTOR ANTAGONIST GENE POLYMORPHISMS

      European journal of clinical investigation
    41. HARTMANN G; BIDLINGMAIER M; JAHRSDORFER B; ENDRES S
      OLIGONUCLEOTIDES - EXTRAPOLATING FROM IN-VITRO TO IN-VIVO

      Nature medicine
    42. HARTMANN G; KRUG A; BIDLINGMAIER M; EIGLER A; ENDRES S
      ANTISENSE STRATEGIES FOR INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS

      Nucleosides & nucleotides
    43. EIGLER A; GRETEN TF; SINHA B; HASLBERGER C; SULLIVAN GW; ENDRES S
      ENDOGENOUS ADENOSINE CURTAILS LIPOPOLYSACCHARIDE-STIMULATED TUMOR-NECROSIS-FACTOR SYNTHESIS

      Scandinavian journal of immunology
    44. EIGLER A; SINHA B; HARTMANN G; ENDRES S
      TAMING TNF - STRATEGIES TO RESTRAIN THIS PROINFLAMMATORY CYTOKINE

      Immunology today
    45. EIGLER A; ENDRES S
      RANDOMIZED CONTROLLED TRIAL OF CDP571 ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN CROHNS-DISEASE

      Zeitschrift fur Gastroenterologie
    46. FOLWACZNY C; ENDRES S
      EFFECT OF AN ENTERIC-COATED FISH-OIL PREP ARATION ON RELAPSES IN CROHNS-DISEASE

      Zeitschrift fur Gastroenterologie
    47. FOLWACZNY C; ENDRES S
      FISH-OIL FOR PREVENTING RELAPSE OF CROHNS -DISEASE

      Zeitschrift fur Gastroenterologie
    48. ENDRES S; FOLWACZNY C
      FISH-OIL FOR PREVENTING RELAPSE OF CROHNS -DISEASE - REPLY

      Zeitschrift fur Gastroenterologie
    49. SCRIBA PC; ENDRES S
      A MEDIATOR, A MALEFACTOR AND A MEDICINE - INTRODUCTION

      Der Internist
    50. ENDRES S; EIGLER A
      INHIBITION OF NITRIC-OXIDE SYNTHASE IN SE PTIC SHOCK - THERAPEUTIC LIMITATIONS AND PERSPECTIVES

      Der Internist
    51. HACKER UT; GOMOLKA M; KELLER E; EIGLER A; FOLWACZNY C; FRICKE H; ALBERT E; LOESCHKE K; ENDRES S
      LACK OF ASSOCIATION BETWEEN AN INTERLEUKIN-1 RECEPTOR ANTAGONIST GENEPOLYMORPHISM AND ULCERATIVE-COLITIS

      Gut
    52. BIDLINGMAIER C; HACKER UT; GOMOLKA M; KELLER E; EIGLER A; FOLWACZNY C; FRICKE H; ALBERT E; LOESCHKE K; ENDRES S
      INFLAMMATORY BOWEL-DISEASE - NO ASSOCIATION BETWEEN ALLELIC POLYMORPHISMS OF IL-1-BETA AND IL-1 RECEPTOR ANTAGONIST GENES

      Gastroenterology
    53. FOLWACZNY C; ENDRES S; HARTMANN G; JOCHUM M; FRICKE H; SPANNAGL M; LOESCHKE K
      HOW ARE THE ANTIINFLAMMATORY PROPERTIES OF HEPARIN IN ULCERATIVE-COLITIS MEDIATED

      Gastroenterology
    54. HACKER UT; GOMOLKA M; KELLER E; EIGLER A; FOLWACZNY C; FRICKE H; ALBERT E; LOESCHKE K; ENDRES S
      LACK OF ASSOCIATION BETWEEN AN INTERLEUKIN-1 RECEPTOR ANTAGONIST GENEPOLYMORPHISM AND ULCERATIVE-COLITIS

      Gastroenterology
    55. SIEGMUND B; EIGLER A; MOELLER J; GRETEN TF; HARTMANN G; ENDRES S
      SUPPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY INTERLEUKIN-10 IS ENHANCED BY CAMP-ELEVATING AGENTS

      European journal of pharmacology
    56. FOLWACZNY C; FRICKE H; ENDRES S; HARTMANN G; JOCHUM M; LOESCHKE K
      ANTIINFLAMMATORY PROPERTIES OF UNFRACTIONED HEPARIN IN PATIENTS WITH HIGHLY-ACTIVE ULCERATIVE-COLITIS - A PILOT-STUDY

      The American journal of gastroenterology
    57. HARTMANN G; BIDLINGMAIER M; EIGLER A; HACKER U; ENDRES S
      CYTOKINES AND THERAPEUTIC OLIGONUCLEOTIDES

      Cytokines cellular & molecular therapy
    58. HARTMANN G; KRUG A; EIGLER A; MOELLER J; MURPHY J; ALBRECHT R; ENDRES S
      SPECIFIC SUPPRESSION OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS BY ANTISENSE OLIGODEOXYNUCLEOTIDES

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    59. HARTMANN G; KRUG A; WALLERFONTAINE K; ENDRES S
      OLIGODEOXYNUCLEOTIDES ENHANCE LIPOPOLYSACCHARIDE-STIMULATED SYNTHESISOF TUMOR-NECROSIS-FACTOR - DEPENDENCE ON PHOSPHOROTHIOATE MODIFICATION AND REVERSAL BY HEPARIN

      Molecular medicine
    60. GRETEN TF; MOELLER J; FELDMEIER H; EIGLER A; ENDRES S
      SYNTHESIS OF TUMOR-NECROSIS-FACTOR-ALPHA IN TISSUE-CULTURE OF RAT CECUM - LACK OF SUPPRESSION BY PHOSPHODIESTERASE INHIBITORS AND PROSTANOIDS

      European journal of gastroenterology & hepatology
    61. MULLER C; JELINEK T; ENDRES S; LOESCHKE K
      TRANSIENT CHOLESTATIC HEPATITIS AFTER GEN ERAL-ANESTHESIA IN A PATIENT WITH ALAGILLES-SYNDROME

      Zeitschrift fur Gastroenterologie
    62. ENDRES S
      N-3 POLYUNSATURATED FATTY-ACIDS AND HUMAN CYTOKINE SYNTHESIS

      Lipids
    63. ENDRES S; WHITAKER RED; GHORBANI R; MEYDANI SN; DINARELLO CA
      ORAL ASPIRIN AND IBUPROFEN INCREASE CYTOKINE-INDUCED SYNTHESIS OF IL-1-BETA AND OF TUMOR-NECROSIS-FACTOR-ALPHA EX-VIVO

      Immunology
    64. ENDRES S; HARTMANN G; EIGLER A; LORENZ R; LOESCHKE K
      LONG-TERM MONITORING OF PLASMA INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH ULCERATIVE-COLITIS

      Gastroenterology
    65. HARTMANN G; KRUG A; EIGLER A; ENDRES S
      SPECIFIC SUPPRESSION OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS BY ANTISENSE OLIGONUCLEOTIDES

      Gastroenterology
    66. GRETEN TF; SINHA B; HASLBERGER C; EIGLER A; ENDRES S
      CICAPROST AND THE TYPE-IV PHOSPHODIESTERASE INHIBITOR, ROLIPRAM, SYNERGIZE IN SUPPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS

      European journal of pharmacology
    67. GROTTRUPWOLFERS E; MOELLER J; KARBACH U; MULLERLISSNER S; ENDRES S
      ELEVATED CELL-ASSOCIATED LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-6 IN INFLAMED MUCOSA OF INFLAMMATORY BOWEL-DISEASE

      European journal of clinical investigation
    68. MILANI RV; MEHRA MR; ENDRES S; EIGLER A; COOPER S; LAVIE CJ; VENTURA HO
      THE CLINICAL RELEVANCE OF CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA IN ACUTE DECOMPENSATED CHRONIC HEART-FAILURE WITHOUT CACHEXIA

      Chest
    69. DRENTH JPH; ENDRES S; BELOHRADSKY BH; VANDERMEER JWM
      HYPERIMMUNOGLOBULINEMIA-D SYNDROME

      Deutsche Medizinische Wochenschrift
    70. SINHA B; SEMMLER J; HAEN E; MOELLER J; ENDRES S
      RADIOIMMUNOASSAYS FOR CYCLIC-AMP CROSS-REACT WITH PHOSPHODIESTERASE INHIBITORS AND BUFFER COMPONENTS

      Journal of pharmacological and toxicological methods
    71. ENDRES S; EISENHUT T; SINHA B
      N-3 POLYUNSATURATED FATTY-ACIDS IN THE REGULATION OF HUMAN CYTOKINE SYNTHESIS

      Biochemical Society transactions
    72. ANGEL JB; SAGET BM; WALSH SP; GRETEN TF; DINARELLO CA; SKOLNIK PR; ENDRES S
      ROLIPRAM, A SPECIFIC TYPE-IV PHOSPHODIESTERASE INHIBITOR, IS A POTENTINHIBITOR OF HIV-1 REPLICATION

      AIDS
    73. GRETEN TF; EIGLER A; SINHA B; MOELLER J; ENDRES S
      THE SPECIFIC TYPE-IV PHOSPHODIESTERASE INHIBITOR ROLIPRAM DIFFERENTIALLY REGULATES THE PROINFLAMMATORY MEDIATORS TNF-ALPHA AND NITRIC-OXIDE

      International journal of immunopharmacology
    74. EIGLER A; MOELLER J; ENDRES S
      EXOGENOUS AND ENDOGENOUS NITRIC-OXIDE ATTENUATES TUMOR-NECROSIS-FACTOR SYNTHESIS IN THE MURINE MACROPHAGE CELL-LINE RAW-264.7

      The Journal of immunology
    75. SCRIBA PC; ENDRES S
      CLINICAL RESEARCH IN GERMANY

      Der Internist
    76. SINHA B; SEMMLER J; EISENHUT T; EIGLER A; ENDRES S
      ENHANCED TUMOR-NECROSIS-FACTOR SUPPRESSION AND CYCLIC ADENOSINE-MONOPHOSPHATE ACCUMULATION BY COMBINATION OF PHOSPHODIESTERASE INHIBITORS AND PROSTANOIDS

      European Journal of Immunology
    77. ENDRES S; DECATERINA R; SCHMIDT EB; KRISTENSEN SD
      N-3 POLYUNSATURATED FATTY-ACIDS - UPDATE 1995

      European journal of clinical investigation
    78. MILANI RV; MEHRA MR; ENDRES S; EIGLER A; COPPER ES; LAVIE CJ; SMART FW; VENTURA HO
      CLINICAL RELEVANCE OF CIRCULATING TNF-A IN DECOMPENSATED ADVANCED HEART-FAILURE

      Circulation
    79. ENDRES S; SINHA B; FULLE HJ
      AMRINONE SUPPRESSES THE SYNTHESIS OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN MONONUCLEAR-CELLS

      Shock
    80. MILANI RV; ENDRES S; VENTURA HO; DAUL CB; WEBER PC; SMART F; STAPLETON D; LAVIE CJ; BARBEE W; MURGO JP
      SUPPRESSION OF TUMOR-NECROSIS-FACTOR SYNTHESIS BY N-3 FATTY-ACIDS IN END-STAGE CONGESTIVE-HEART-FAILURE

      Journal of the American College of Cardiology
    81. DECATERINA R; ENDRES S; KRISTENSEN SD; SCHMIDT EB
      N-3 FATTY-ACIDS AND RENAL DISEASES

      American journal of kidney diseases
    82. SIEBECK M; KOHL J; ENDRES S; SPANNAGL M; MACHLEIDT W
      DELAYED TREATMENT WITH PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTWEB-2086 ATTENUATES PULMONARY DYSFUNCTION IN PORCINE ENDOTOXIN-SHOCK

      The journal of trauma, injury, infection, and critical care
    83. MARKEWITZ A; FAIST E; WEINHOLD C; LANG S; ENDRES S; HULTNER L; REICHART B
      ALTERATIONS OF CELL-MEDIATED IMMUNE-RESPONSE FOLLOWING CARDIAC-SURGERY

      European journal of cardio-thoracic surgery
    84. ENDRES S; MEYDANI SN; GHORBANI R; SCHINDLER R; DINARELLO CA
      DIETARY SUPPLEMENTATION WITH N-3 FATTY-ACIDS SUPPRESSES INTERLEUKIN-2PRODUCTION AND MONONUCLEAR CELL-PROLIFERATION

      Journal of leukocyte biology
    85. SEMMLER J; WACHTEL H; ENDRES S
      THE SPECIFIC TYPE-IV PHOSPHODIESTERASE INHIBITOR ROLIPRAM SUPPRESSES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY HUMAN MONONUCLEAR-CELLS

      International journal of immunopharmacology
    86. EISENHUT T; SINHA B; GROTTRUPWOLFERS E; SEMMLER J; SIESS W; ENDRES S
      PROSTACYCLIN ANALOGS SUPPRESS THE SYNTHESIS OF TUMOR-NECROSIS-FACTOR-ALPHA IN LPS-STIMULATED HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      Immunopharmacology
    87. GROTTRUP E; MOELLER J; KARBACH U; ENDRES S
      ELEVATED LEVELS OF IL-1-BETA AND IL-6 BUT NOT OF TNF-ALPHA IN INFLAMED MUCOSA OF INFLAMMATORY BOWEL-DISEASE

      Gastroenterology
    88. KRISTENSEN SD; DECATERINA R; SCHMIDT EB; ENDRES S
      FISH-OIL AND ISCHEMIC-HEART-DISEASE

      British Heart Journal
    89. EIGLER A; SINHA B; ENDRES S
      NITRIC OXIDE-RELEASING AGENTS ENHANCE CYTOKINE-INDUCED TUMOR-NECROSIS-FACTOR SYNTHESIS IN HUMAN MONONUCLEAR-CELLS

      Biochemical and biophysical research communications
    90. ENDRES S
      MESSENGERS AND MEDIATORS - INTERACTIONS AMONG LIPIDS, EICOSANOIDS, AND CYTOKINES

      The American journal of clinical nutrition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 19:22:35